A detailed history of Cx Institutional transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cx Institutional holds 3,499 shares of CRL stock, worth $704,978. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,499
Previous 3,479 0.57%
Holding current value
$704,978
Previous $822,000 15.33%
% of portfolio
0.05%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$203.52 - $273.43 $4,070 - $5,468
20 Added 0.57%
3,499 $948,000
Q4 2023

Jan 12, 2024

BUY
$164.52 - $238.84 $21,881 - $31,765
133 Added 3.97%
3,479 $822,000
Q3 2023

Oct 17, 2023

BUY
$194.44 - $217.61 $3,694 - $4,134
19 Added 0.57%
3,346 $655,000
Q2 2023

Jul 26, 2023

BUY
$183.71 - $210.25 $31,230 - $35,742
170 Added 5.38%
3,327 $699,000
Q1 2023

May 04, 2023

BUY
$191.89 - $259.92 $2,110 - $2,859
11 Added 0.35%
3,157 $637,000
Q4 2022

Feb 03, 2023

BUY
$197.11 - $250.07 $7,490 - $9,502
38 Added 1.22%
3,146 $685,000
Q3 2022

Nov 04, 2022

BUY
$182.44 - $250.54 $912 - $1,252
5 Added 0.16%
3,108 $612,000
Q2 2022

Aug 02, 2022

SELL
$204.13 - $302.4 $1,428 - $2,116
-7 Reduced 0.23%
3,103 $664,000
Q1 2022

May 09, 2022

BUY
$255.51 - $362.11 $511 - $724
2 Added 0.06%
3,110 $883,000
Q4 2021

Jan 18, 2022

BUY
$351.38 - $448.68 $702 - $897
2 Added 0.06%
3,108 $1.17 Million
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $745 - $916
-2 Reduced 0.06%
3,106 $1.28 Million
Q3 2020

Oct 13, 2020

BUY
$175.56 - $226.45 $175 - $226
1 Added 0.03%
3,108 $704,000
Q2 2020

Aug 06, 2020

BUY
$118.84 - $189.72 $831 - $1,328
7 Added 0.23%
3,107 $542,000
Q3 2019

Oct 10, 2019

SELL
$125.07 - $143.67 $1,750 - $2,011
-14 Reduced 0.45%
3,100 $410,000
Q2 2019

Jul 17, 2019

BUY
$123.4 - $148.55 $1,727 - $2,079
14 Added 0.45%
3,114 $442,000
Q4 2018

Jan 14, 2019

BUY
$105.09 - $137.23 $325,779 - $425,412
3,100 New
3,100 $351,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.